載入...
Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the sixth most prevalent cancer worldwide with rates of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC) dramatically increasing. The overexpression of enhancer of zeste homolog 2 (EZH2), a histone methyltransferase responsible f...
Na minha lista:
| 發表在: | Clin Epigenetics |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5586065/ https://ncbi.nlm.nih.gov/pubmed/28878842 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13148-017-0390-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|